Archive: Jan 2018

Happi: FDA Is Getting Personal


Posted on January 9th, 2018, by Bell International Laboratories in Blog Post


Warning letters reiterate Agency priorities, target consumer reviews and trigger consumer class actions. Authors: Raqiyyah Pippins and Krithika Santhanam Click here for Original story on Happi.com. By now, it is no secret that the Food and Drug Administration (FDA) is monitoring personal care product1 marketing and using warning letters to remind companies of what causes a product […]